Business
FDA grants broader orphan drug status to PTX100 for TCLs
FDA grants broader orphan drug status to PTX100 for TCLs
About this update from Prescient Therapeutics Limited
[{"type":"text","content":"Prescient Therapeutics Ltd has released a press release. View Attachment","length":253,"tagName":"div"}]